This is the earnings call script for the fourth quarter 2024. Thank you for joining Reading International's earnings call to discuss our 2024 fourth quarter and full year results. My name is Andrzej Matyczynski, and I am Reading's Executive Vice President of Global Operations. With me are Ellen Cotter, our President and Chief Executive Officer, and Gilbert Avanes, our Executive Vice President, Chief Financial Officer, and Treasurer. Before we begin the substance of the call, I will run through the usual caveats. In accordance with the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995, certain matters that will be addressed in this earnings call may constitute forward-looking statements. Such statements are subject to risks, uncertainties, and other factors that may cause our actual performance to be materially different from the performance indicated or implied by such statements. Such risk factors are clearly set out in our SEC filings. We undertake no obligation to publicly update or revise any forward-looking statements. In addition, we will discuss non-GAAP financial measures on this call. Reconciliations and definitions of non-GAAP financial measures, which are Segment Operating Income, EBITDA, and Adjusted EBITDA, are included in our recently issued 2024 fourth quarter corrected earnings release released on April 1 on our company's website. We have adjusted, where applicable, the EBITDA items we believe to be external to our business and not reflective of our cost of doing business or results of operations. Such costs could include legal expenses relating to extraordinary litigation and any other items that we can consider to be non-recurring in accordance with the two-year SEC requirement for determining whether an item is non-recurring, infrequent, or unusual in nature. We believe that the adjusted EBITDA is an important supplemental measure of our performance. In today's call, we also use an industry-accepted financial measure called Theater Level Cash Flow (TLCF), which is Theater Level Revenue less Direct Theater Level Expenses. Average Ticket Price (ATP), which is calculated by dividing cinema box office revenue by the number of cinema admissions, is also used as an accepted industry acronym. We will also use a measure referred to as Food and Beverage Spend Per Patron (F&B SPP), which is a key performance indicator for our cinemas. The F&B SPP is calculated by dividing a cinema's revenues generated by food and beverage sales by the number of admissions at that cinema. Please note that our comments are necessarily summary in nature, and anything we say is qualified by the more detailed disclosure set forth in our Form 10-K and other filings with the US Securities and Exchange Commission. With that behind us, I'll turn it over to Ellen, who will review our 2024 fourth quarter and full year results, and discuss our business strategy going forward, followed by Gilbert, who will provide a more detailed financial review. Ellen? Thanks, Andrzej, and welcome everyone to the call today, and thank you for listening in. Let's start with the fourth quarter 2024 results, which were encouraging and we believe reinforced our confidence in Reading's long-term future. Thanks to both an amazing lineup of blockbuster movies like Wicked, Moana 2, Gladiator II, Sonic the Hedgehog 3, and Mufasa, and our management team's collaborative efforts, each of Reading's key operational metrics—total revenues, operating income, and adjusted EBITDA—all significantly improved compared to 2023's fourth quarter. At $58.6 million, our Q4 2024 global total revenue was 29% higher than Q4 2023, and the best fourth quarter since Q4 2019. Our Q4 2024 global operating income of $1.5 million increased $8.5 million, or 122% from a global operating loss of $7 million in Q4 2023, and represented the first fourth quarter since Q4 2019 that we enjoyed positive operating income. At $6.8 million, our Q4 2024 adjusted EBITDA increased over 400% from a negative adjusted EBITDA of $2.2 million in Q4 2023, and represented the highest fourth quarter EBITDA since Q4 2019. Our Q4 2024 global cinema revenue of $54.6 million was 30% above Q4 2023 and represented just under 84% of pre-pandemic Q4 2019 levels. At $3.8 million, our Q4 2024 global cinema operating income was 191% ahead of Q4 2023 and represented the best fourth quarter global cinema operating income since Q4 2019. In highlighting the significant progress our company has made since the first year of the pandemic, our Q4 2020 operating loss was $11.7 million. Again, looking forward to Q4 2024, we had a positive $3.8 million operating income, a 132% increase. As many of you know, we operate in two industries: cinema and real estate, in three countries: the US, Australia, and New Zealand. Currently, over 93% of our revenues come from our cinema business. The global macro events we've navigated, particularly the impacts of COVID-19 and the 2023 Hollywood strikes, have posed very serious challenges for us. Through these choppy waters, we've relied on our real estate assets and our global real estate division. In Q4 2024, we reported global real estate revenues of $5.2 million, a 14% increase over the same period in 2023, and at $1.4 million, our operating income increased 148% over last year's Q4. This quarter, these favorable results were driven by our improved live theater operation and rent revenue from Petco, our tenant at 44 Union Square. However, the division continues to be supported by our 74 third-party Australia-New Zealand tenant portfolio, which has a 96% occupancy rate. Let's turn to the full year. The 2023 Hollywood strikes and the resultant release date shifts had a major impact on the first part of 2024 for us and for the industry, and ultimately dragged the overall year down. We reported total revenue of $210.5 million, a 5% decrease from 2023, and 76% of our 2019 total revenue of $276.8 million. Our global operating loss increased by 17% to $14 million. Our 2024 global cinema revenue was $195.1 million, which was 6% less than 2023 and equates to 74% of 2019's global cinema revenues. This revenue reduction also reflects the fact that we've closed four underperforming cinemas in the US since the second half of 2023, and also reflects the Australian and New Zealand dollar decline that's happened between 2024 and 2023. On the other hand, our global real estate division delivered solid 2024 results, with revenues of $20 million, which is a slight increase over 2023, and an operating income of $4.7 million, a 23% year-over-year increase. One of our company's key short-term priorities is to lower our interest expense by reducing or refinancing our debt. As we await a global cinema business that delivers more wide titles more consistently throughout the year, our board has directed management to assess our global real estate portfolio to identify assets that can be sold to generate liquidity to pay down debt over the next few years. Through 2024, we took steps to monetize certain assets. We sold our office building in Culver City for $10 million, paid off the $8.4 million mortgage, which will reduce our interest expense and our overall G&A expenses going forward. After years of working together with the Wellington City Council in New Zealand, in April 2024, we faced a sudden and unexpected termination of the negotiations related to a potential sale leaseback transaction. Following this termination, our board decided to monetize our property assets in Wellington, New Zealand, including our Courtenay Central building. We completed that sale by the end of 2024, but closed on January 31, 2025, for NZD 38 million. In 2024, we negotiated and documented a sale transaction, which included a leaseback provision that will permit us to refurbish and reopen our Courtenay Central cinema after the building has been seismically upgraded by the new owner. With these funds from the sale of our Wellington assets, we repaid our entire Westpac debt of NZD 18.8 million and repaid just over $6 million to our Bank of America. In the U.S., we've been advancing sales efforts with respect to our approximately 24-acre Newberry Yard asset in Williamsport, Pennsylvania. The yard, as the name suggests, is integrated into the area's rail system. We believe that we'll benefit from the resurgence of fracking and other economic activity in Pennsylvania. Based on the current interest from various industrial users, while no assurances can be given, we believe that we will transact on that property sometime this year. In Australia, we've been working on the sale of our Cannon Park property asset in Townsville, in Queensland, and have executed an option to sell with purchase and sale agreements annexed, with a targeted Q2 2025 settlement date for a sales price of AUD 32 million. In Queensland, for tax purposes, real property sale agreements that include a due diligence component are structured as option agreements. While the option holder has made a $1.6 million earnest money deposit, no assurances can be given that this transaction will close as a potential buyer is still in its due diligence period. Through 2025, we will continue to develop opportunities for asset monetization that will assist our overall liquidity conditions. Now, let's take a closer look at our global cinema business, which has traditionally served as our core source of cash flow driving our asset growth strategy. As I just mentioned, our Q4 2024 global cinema revenues and global operating income were both up substantially due to the powerful holiday film slate that was delivered by the major studios, but also by the focus on profitability of our executive programming operations and marketing teams. While the fourth quarter was great, the full year of 2024, as I mentioned before, trailed behind 2023, with the first part of 2024 being materially impacted by the release date changes due to the Hollywood strikes. While the fourth quarter 2024 was very encouraging, this quarter that we're in now, first quarter of 2025, overall will likely be a disappointment in comparison to last year due to a softer overall film slate. We see light at the end of the tunnel, with the remainder of the 2025 movie lineup looking exciting, diverse, and very promising. Families can come together to watch Lilo & Stitch, How to Train Your Dragon, Disney's Elio, Zootopia 2. Superhero fans will be entertained by Thunderbolts, The Fantastic Four, and Blade, all from the MCU, and Superman from DC Universe. Huge franchises return: Karate Kid: Legends, Jurassic World: Rebirth, Mission: Impossible - The Final Reckoning, Wicked Part Two, and Avatar: Fire and Ash. Right now, I'm here at CinemaCon this week, and some of the original product that we've seen looks really sensational, like The Bride from director Maggie Gyllenhaal, and F1, the new racing movie from the makers of Top Gun: Maverick, director Joe Kosinski, and producer Jerry Bruckheimer. I'll touch on some of the more country-specific milestones in a minute, but let me first highlight a few of the key strategic initiatives that are being pursued, that have been and are being pursued by our global teams through 2024 and into 2025. Throughout 2024 and into 2025, our global programming teams have remained committed to curating original series and programming compelling content that engages audiences and boosts ticket sales. Creating original film series has been a key focus of ours for a while to keep audiences engaged during periods at the time that the studios do not have a consistent flow of product. We are also always exploring new avenues for alternative content. This effort falls on both the programming and marketing teams. Our success with these programs is not only dependent on programming great content, but equally on executing impactful campaigns across our digital and social channels and creating community-based promotional partnerships. Our F&B program is always a main focus for our global management teams. In 2024, the F&B SPP for all three of our cinema divisions reached annual record highs for any previous year for the full year of 2024. With respect to the fourth quarter 2024, the F&B SPP for each cinema division was the highest fourth quarter ever, if you measure when all of our screens were open, or in other words, excluding certain pandemic periods when only certain screens were operational. Through the year, we focused on improving the convenience and functionality behind our F&B sales online and on our app, with transaction sizes consistently improving. We again embraced movie-themed menus in all three countries and offered our guests movie-inspired cocktails, burgers, or desserts. In the US, we're following the merchandise trends and selling very fun merchandise for some of our most important films. In Australia and New Zealand, as of today, 75% of our theaters are selling liquor, and in the US, 100% of our theaters are selling beer and wine, and in all but three are selling liquor. Understanding the price sensitivities that various audiences feel, in the U.S., we launched a comprehensive weekday discount program, which offers guests value-driven discounts on select F&B items throughout the week as opposed to the weekend. For instance, on Mondays, you could get a Mega Movie Combo; on Tuesdays, we offer a BOGO sweet treat, etc. With regard to loyalty and rewards, we're driving guests to our theaters through our existing programs and are working to develop new and improved rewards and loyalty programs. In Australia and New Zealand, during the last half of 2024, we revamped and relaunched our free- to-j oin Reading Rewards program to provide better perks and savings. Today, we have over 300,000 members. In late Q4 2024, we also launched paid loyalty programs for both our Reading and Angelika brands. Since launch, we've signed up over 6,000 paid memberships. In the U.S., we have a free- to-j oin Angelika membership program with over 155,000 members for eight theaters. We will launch a premium monthly membership within the next three to four months. We have an existing free- to-j oin program in Hawaii at Consolidated Theatres that will be also rolled into a new free- to-j oin and paid membership for Consolidated within the next four to six months. At the same time, we will roll out a similar offer at our U.S.-based Reading cinemas. Another key effort for our global executive teams has been to work with our landlords to try to recalibrate our occupancy costs to reflect the reality of what we have been living over the last few years. Today, attendance is not back to pre-pandemic levels, and most of our operating expenses are up. We have prioritized collaborating with our landlords to try and achieve occupancy cost reductions where we can. Now, let's turn to our US cinema division and starting with the fourth quarter 2024. Our US cinema revenue increased by 24% to $29.3 million compared to Q4 2023, and it was the highest Q4 revenue since Q4 2019. Our US operating loss improved by $4.2 million to a positive operating income of $1.6 million from an operating loss of $2.6 million in Q4 2023. This is also the highest Q4 operating income since Q4 2019. These results were achieved despite the streamlining of our circuit. The fourth quarter of 2023 includes revenues from two US cinemas that have since closed. Since the pandemic, we have closed five underperforming US-based theaters, three in Hawaii, one in California, and one in Texas, with four of these closures occurring in the last two years. As we've reported before, we anticipate that these closures will positively impact our future profitability, even if they adversely impact our gross revenue line. We enjoyed a really compelling film slate that worked for our audience during the fourth quarter. Moana worked very well at Consolidated Theatres. Wicked worked well at many of our theaters across the US, and our specialty theaters did very well with certain films, but most particularly Anora and The Brutalist from A24. For the full year 2024, our US cinema revenue decreased by 12% to $99.9 million compared to the full year of 2023. Our operating loss increased to $7.3 million, up from an operating loss of $5.8 million for the year ended December 31, 2023. The drivers for the US underperformance for the full year of 2024 were, as I've said before, a decrease in the cinema performance due to the lingering impacts of the 2023 Hollywood strikes, which resulted in lower box office revenue, lower F&B revenue, and lower advertising revenues. This was partially offset by a decrease in depreciation, amortization, G&A expense, and lower operating expenses. Our fourth quarter 2024 F&B SPP was $8.28, which represented the highest fourth quarter ever for a US circuit and represented a higher number than certain of our major publicly traded exhibitors, competitors, excuse me, and comes during a time when we rolled out the weekday deal program that I've just described. Our year-to-date F&B SPP of $8.12, $8.12 represented the highest year-to-date F&B SPP ever. Additionally, our fourth quarter theater rental revenues helped make the ancillary revenue for a U.S. circuit the highest fourth quarter on record. Reflecting the laser focus of our management team, the U.S.'s fourth quarter 2024 cash flow pre-occupancy per capita was the highest quarter ever recorded. Now, let's turn to our cinemas in Australia and New Zealand. In Q4 2024, and compared to Q4 2023, our Australian cinema revenue increased 37% to AUD 21.4 million, and our operating income increased 254% to AUD 1.7 million from an operating loss of AUD 1.1 million. Our New Zealand cinema revenue increased 53% to NZD 3.8 million, and operating income increased 228% to NZD 504,000 from an operating loss of NZD 395,000. If you looked at these increases in their local currency, the results would be even more impressive. Here are some of the fourth quarter 2024 milestones. Supported by a terrific film lineup that worked well with our audiences in Australia and New Zealand, our Australian cinema division's cinema revenue of AUD 21.4 million marked the highest fourth quarter performance since Q4 2019. At AUD 1.7 million, our Australian cinema division's operating income also marked the highest fourth quarter performance since Q4 2019. Our Q4 2024 admission revenue in Australia and New Zealand were higher than Q4 2023, with a 37% increase for Australia and a 38% increase for New Zealand. In functional currency, our Australian F&B revenue of AUD 10.6 million is the highest fourth quarter of all time for F&B revenues. Australia had its best full year and fourth quarter revenues in terms of both food and beverage and screen advertising in functional currency for the 2024 full year and the fourth quarter 2024. The Q4 2024 screen advertising revenue in Australia was supported in part by the rollout of another circuit-wide Click to Pay program with Mastercard. Our Australia Q4 2024 ATP of AUD 15.27 in functional currency and our F&B SPP of AUD 8.28 in functional currency were both the highest fourth quarter ever. The fourth quarter 2024 cash flow pre-occupancy per capita in Australia was its highest fourth quarter ever recorded, again when measured in local currency, and also, like the U.S., reflecting the laser focus of our management teams. In Australia, our total theater-level cash flow delivered the highest fourth quarter since 2019 for Australian cinemas. Rounding out with our New Zealand cinemas, our Q4 2024 ATP of NZD 13.20 and our F&B SPP of NZD 6.98, again functional currency, were the highest quarters ever. Now, let's turn to our global real estate business, which on a segment reporting basis includes our live theater business in New York City and our intercompany rents. Let's start with the fourth quarter 2024 results. At $5.2 million, our global real estate total revenue increased 14%, while our total operating income of $1.4 million increased by 148%. These increases were driven by our live theater revenue as a result of increased show activity and license fees through the quarter at the Orpheum, and Audible at the Minetta Lane presented multiple shows during the fourth quarter, including I'm Almost There by Todd Almond, Samantha Bee's How to Survive Menopause, and Strategic Love Play. Lastly, the quarter was improved due to the rent revenues delivered by Petco, who has a flagship store at our 44 Union Square building in New York City. Let me point out a few standout fourth quarter 2024 real estate division metrics. Driven by the US property and US live theater performance, our Q4 2024 real estate operating income of $1.4 million is the best quarter since Q3 2019. That result takes into account, among other things, the sales of our Maitland property in New South Wales in the fourth quarter of 2023 and the sale of Auburn Redy ard in June of 2021. Recall you will recall, we had 17 third-party tenants at that property. Our US real estate business, which includes our two theaters in New York City, achieved an improved year-over-year result and achieved its highest fourth quarter revenue ever, supported by the rent from 44 Union Square. This quarter's operating income was 25% higher than Q4 2019's operating income, despite the elimination of rental revenue associated with our Culver City office building, which we sold in the first quarter of 2024, and the Q4 2023 sale of our Maitland property in New South Wales. For the full year 2024, our global real estate revenue of $20 million increased by 1% compared to 2023, and our operating income of $4.7 million increased 23% from an operating income of $3.8 million in 2023. While the increases quarter over quarter and year over year might have been attributed to the improved US business, these results continue to be founded and supported by the 74 third-party Australian and New Zealand real estate portfolio, which today reflects a 96% occupancy rate. With 2024's results being ahead of 2023 on a yearly and quarterly basis, we're excited to continue to build upon this positive momentum as it pertains to our real estate business. In addition to maintaining our real estate operations, to bolster our long-term liquidity during the last several months in 2024, we focused on monetizing four select real estate assets: Culver City, Wellington, Cannon Park, and Williamsport. We worked with our lenders on various financings to extend our maturity dates, which Gilbert will touch on in a minute. We've now monetized Culver City and Wellington. Cannon Park is under contract and is in its due diligence phase. While no assurances can be given, we currently anticipate a closing on that sale, the Cannon Park sale, sometime this quarter. Williamsport's rail easement issues having been resolved, it's now ready to be sold to a new owner with rail access needs. While no assurances can be given, we do anticipate a closing on that asset before the end of the year. We've also embarked on a detailed review of all of our historic railroad properties and have retained an outside consultant to help us in this effort to determine whether there are additional monetization opportunities existing in our historic rail portfolio. This will be a focus for us in 2025. All of these real estate-based efforts and momentum should line us up nicely to be ready for the improvement in the box office expected for 2025 and beyond, and the reduction, hopefully, in interest rates that should continue in the middle of 2025. That wraps it up for me. I'm going to turn it over to Gilbert. Thank you, Ellen. Consolidated revenue for the quarter ended December 31, 2024, increased by $13.3 million to $58.6 million when compared to the fourth quarter of 2023 as a result of a stronger film slate and higher live theater and U.S. property revenue in the fourth quarter of 2024. Consolidated revenue for the 12 months ended December 31, 2024, decreased by $12.2 million to $210.5 million when compared to the 12 months ended December 31, 2023. This decrease is primarily attributable to the lower attendance in the U.S. and New Zealand as a result of overall lower performing titles for our theaters in 2024 compared to 2023, along with closing cinemas in these specific countries. Net loss attributable to Reading International for the quarter ended December 31, 2024, decreased by $10.1 million to a loss of $2.2 million compared to a loss of $12.4 million in Q4 2023. Q4 2024 basic loss per share decreased by $0.46 to a basic loss per share of $0.10 compared to a basic loss per share of $0.56 for Q4 2023. These results were primarily due to strengthened cinema performance in all three countries, strengthened US and Australia property performance, decreased interest expense, reduced depreciation and amortization, and increased other income. Net loss attributable to Reading International for 12 months ended December 31, 2024, increased by $4.6 million to a loss of $35.3 million from a loss of $30.7 million when compared to the 12 months ended December 31, 2023. Basic loss per share increased by $0.20 to a loss of $1.58 compared to a loss of $1.38 for the 12 months ended 2023. These results were primarily due to a decrease in cinema segment revenue due to a weaker movie slate as a result of lingering impact of 2023 Hollywood strike, a $1.7 million increase in interest expense due to rising interest rate, and a $1.4 million loss on sale of asset primarily from the sale of the Culver City office, partially offset by a decreased depreciation and amortization and increased other income. Our total company depreciation, amortization, impairment, and general and administrative expenses for the quarter ended December 31, 2024, decreased by $0.8 million to $8.2 million compared to Q4 2023. For the 12 months ended December 31, 2024, it decreased by $2.7 million to $35.9 million compared to the 12 months ended December 31, 2023. These decreases were due to decreases in depreciation and amortization as a result of sale of our Maitland and Culver City property and no depreciation on our held for sale properties. Income tax expense for the quarter ended December 31, 2024, decreased by $0.1 million to $0.2 million compared to Q4 2023. Income tax expense for the 12 months ended December 31, 2024, decreased by $0.1 million to $0.5 million compared to the 12 months ended December 31, 2023. The decrease in income tax expense is due to an adjustment for the valuation allowance recorded in 2024 compared to 2023. For the fourth quarter of 2024, our adjusted EBITDA income increased by $9 million to an EBITDA income of $6.8 million from an EBITDA loss of $2.2 million in Q4 2023. For the 12 months ended December 31, 2024, our adjusted EBITDA income decreased by $5.6 million to $2.1 million compared to an EBITDA income of $7.8 million for the 12 months ended December 31, 2023. Shifting to cash flow, for the 12 months ended December 31, 2024, net cash used in operating activities decreased by $5.9 million to $3.8 million compared to cash used in 12 months ended December 31, 2023, of $9.7 million. This was primarily driven by an $11.7 million increase in net change in operating assets and liabilities, primarily due to a decrease in receivables and an increase in accounts payable and accrued expenses, plus deferred revenues and other liabilities, partially offset by an increase in net operating loss of $3.4 million. Cash provided in investing activities during the 12 months ended December 31, 2024, increased by $6.7 million to $4 million compared to cash used in the 12 months ended December 31, 2023, of $2.7 million. This was primarily due to proceeds from the sale of our Culver City office. Cash provided in financing activities for the 12 months ended December 31, 2024, increased by $7 million to $0.3 million compared to cash used in the 12 months ended December 31, 2023, of $6.7 million. This was primarily due to a new bridge loan of $12 million from NAB and an increase of $5 million from our Westpac loan. This increase was partially offset by the payoff of our Citizens loan of $8.4 million following the sale of the Culver City office building and scheduled repayment on other debts. Turning now to our financial position, our total assets on December 31, 2024, were $471 million compared to $533.1 million on December 31, 2023. This decrease was driven by a $2.8 million decrease in cash and cash equivalent and receivables, from which we funded our ongoing business operations, a $10.1 million decrease in operating properties as a result of the sale of our Culver City office, a $15.8 million decrease due to depreciation and amortization, and a $20.7 million decrease in operating lease right-of-use assets. As of December 31, 2024, our total outstanding borrowings were $202.7 million compared to $210.3 million on December 31, 2023. Our cash and cash equivalent as of December 31, 2024, were $12.3 million, which includes approximately $5 million in US, $6.4 million in Australia, and $0.9 million in New Zealand. Further, to address liquidity pressure on our business, we are working on our lenders to amend certain debt facilities, and we have selected certain real estate assets for potential monetization and have listed them for sale. During the first quarter of 2024, we completed the monetization of our Culver City LA office building for $10 million and fully discharged the related mortgage with Citizens. During 2024 and the first quarter of 2025, we made progress with our lenders on the following financing arrangement. On August 1, 2024, we extended the maturity to June 1, 2025, and two required $250,000 principal payments were repaid on August 23, 2024, and December 27, 2024, respectively. At Bank of America, on March 27, 2024, we extended our Bank of America loan maturity date to August 18, 2025, together with modification of certain financial covenants. We have been working with the bank to defer monthly payments, and following the sale of our Courtenay property, we repaid $6.1 million of our Bank of America loan on February 5, 2025. On Valley National, on October 1, 2024, we obtained two further six-month extensions for our loan with Valley National. We exercised the second extension on February 26, 2025, with maturity updates to October 1, 2025. We have increased our cash deposit with Valley National by $1 million to a balance of approximately $2.1 million. Emerald Creek Capital. On April 23, 2024, we exercised the one-year extension option for the loans with Emerald Creek Capital to extend the maturity to May 6, 2025. Our plan is to exercise a further option to extend the maturity. Our National Australia Bank. On April 4, 2024, we extended the NAB loan maturity date to July 31, 2026, and NAB also provided a bridge facility of AUD 20 million. On June 28, 2024, we entered into an interest rate collar hedge agreement with NAB for AUD 50 million, where the cap rate is 4.78% and the floor of 4.18%. The termination date of the agreement is July 31, 2026. On December 17, 2024, we extended the maturity of an AUD 20 million bridge facility from March 31 to April 30, 2025. On February 19, 2025, we executed an amendment to lower the liquidity requirements from $5 million to $2.5 million until April 30, 2025. Westpac. On August 13, 2024, we increased our Westpac corporate credit facility by NZD 5 million to NZD 18.8 million. On December 20, 2024, we extended the maturity to March 31, 2025. On January 31, 2025, we repaid the loan, and the loan was discharged. With that, I will now turn it over to Andrzej. Thanks, Gilbert. As usual, I'd like to thank our stockholders for forwarding questions to our investor relations email. In addition to addressing many of your questions in the prepared remarks from Ellen and Gilbert, we've selected a few additional questions to offer additional insights from management. The first question: What are your capital allocation priorities for 2025, and how should we think about CapEx spending for this year and the next? Ellen? In 2025, our highest priority is to reduce debt. However, we are working on plans right now to upgrade at least four theaters: one in Australia, two in the U.S., and one in New Zealand. The upgrades would include converting certain auditoriums to luxury recliner seating and adding premium screens. Ultimately, the final execution of these plans will be subject to the strength of the box office over the next three quarters in 2025 and the execution of potential asset sales. Thanks, Ellen. We also received some stockholder questions about the size of our global cinema portfolio. What are the recent underperforming theater closures? About how much annually will these closed theaters save the company in aggregate? How many Reading cinema screens remain on difficult leases or are underperforming such that they are candidates for a 2025 closure? What are the expected cost savings of these decisions? Ellen? In 2025, in the U.S., we're closing one U.S.-based cinema. We're closing it this month in April. Based on the box office trends over the last few years and the occupancy levels that would be required by the landlord, we'd expect cash savings to be between $500,000 and $1 million per year. In New Zealand, we did close another theater, a small theater, a few months ago. If you look at the box office trends over the last few years and the occupancy levels, we expect to save about maybe $100,000 to $200,000 a year. Right now, we've got no immediate plans to close any other theaters in the U.S., Australia, or New Zealand, but I'll note that we are in communications with our landlords. If there was an opportunity to exit a lease without any sort of economic penalty for a theater that does not have a consistent cash flow history, we would likely pursue that opportunity to continue to streamline our circuit. Thanks again, Ellen. While you're on the roll, can you handle this one? Is your Australian cinema development project in Noosa still on track for 2026? Any other projected developments? What are the screen count, timing, and milestones providing more info on the prospective projects known to be going forward? Yes, we're still working with the Stockwell development team on the Reading Cinema in Noosa, which is in Queensland, Australia. The project, which includes the cinema, is in the town planning phase right now. As of today, we would expect the opening date to be pushed out a year or so, so likely a 2027 opening. In Australia, while we're always monitoring the market for new cinema opportunities, whether it's an acquisition, a new build, or a management deal, as of today, other than Noosa, we don't have any new deals to report to our stockholders. Thanks, Ellen. We'll finish up with this last question, which I'll field regarding the comment that we failed to follow through and deliver on our promise of two non-deal roadshows and an additional microcap investor conference before the year-end of 2024. We had earlier said it was working on and has done nothing to engage with a broader set of investors in all of 2024. Explain why not. We'll take the mea culpa, and rather than dwelling on the past, we have begun discussions with one of our analysts with a view to bringing to fruition the promised two non-deal roadshows during 2025. Furthermore, we are finalizing our participation in a microcap virtual conference for mid-May of this year. Following these efforts, we will reevaluate the way forward for our investor relations strategy. That marks the conclusion of our call. We appreciate your listening to the call today. We thank you for your attention, and we wish everyone good health and a safe 2025. Thank you.